Article
Boston - Just as the trend in psoriasis treatment veers toward more systemic modalities with the biologic revolution, a new topical treatment with low toxicity may provide solutions for patients who have not responded to conventional therapy.
Developing an OTC Dermatology Product
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Pediatric Patients with Atopic Dermatitis Have Lower SCH and Higher TEWL, Compared to Those Without
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Optimizing Care for Patients with Urticaria
Denise Dajles, DEng, MSc, Ushers in a New Era at Cytrellis Biosystems, Looks to Future of Aesthetics Industry